These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35911754)

  • 1. The Therapeutic Potential of Targeting NIK in B Cell Malignancies.
    Haselager MV; Eldering E
    Front Immunol; 2022; 13():930986. PubMed ID: 35911754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer.
    Pflug KM; Sitcheran R
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.
    Razani B; Zarnegar B; Ytterberg AJ; Shiba T; Dempsey PW; Ware CF; Loo JA; Cheng G
    Sci Signal; 2010 May; 3(123):ra41. PubMed ID: 20501937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NIK-IKK complex interaction controls NF-κB-dependent inflammatory activation of endothelium in response to LTβR ligation.
    Kucharzewska P; Maracle CX; Jeucken KCM; van Hamburg JP; Israelsson E; Furber M; Tas SW; Olsson HK
    J Cell Sci; 2019 Apr; 132(7):. PubMed ID: 30837284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide-induced activation of NF-κB non-canonical pathway requires BCL10 serine 138 and NIK phosphorylations.
    Bhattacharyya S; Borthakur A; Dudeja PK; Tobacman JK
    Exp Cell Res; 2010 Nov; 316(19):3317-27. PubMed ID: 20466000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
    Cherry EM; Lee DW; Jung JU; Sitcheran R
    Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of basally translated NF-kappaB-inducing kinase (NIK) protein functions as a molecular switch of processing of NF-kappaB2 p100.
    Qing G; Qu Z; Xiao G
    J Biol Chem; 2005 Dec; 280(49):40578-82. PubMed ID: 16223731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase.
    Ramakrishnan P; Wang W; Wallach D
    Immunity; 2004 Oct; 21(4):477-89. PubMed ID: 15485626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling.
    Kanno Y; Sakurai D; Hase H; Kojima H; Kobata T
    J Recept Signal Transduct Res; 2010 Apr; 30(2):121-32. PubMed ID: 20184394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma.
    Mazzera L; Abeltino M; Lombardi G; Cantoni AM; Ria R; Ricca M; Saltarella I; Naponelli V; Rizzi FMA; Perris R; Corradi A; Vacca A; Bonati A; Lunghi P
    Haematologica; 2019 Dec; 104(12):2465-2481. PubMed ID: 30948493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the NIK aly mutation on NF-kappaB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40.
    Luftig MA; Cahir-McFarland E; Mosialos G; Kieff E
    J Biol Chem; 2001 May; 276(18):14602-6. PubMed ID: 11278268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the binding pattern of NIK inhibitors by computational simulation.
    Tang Y
    J Biomol Struct Dyn; 2024 Apr; 42(7):3318-3331. PubMed ID: 37183664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinase NIK as a therapeutic target in multiple myeloma.
    Gardam S; Beyaert R
    Expert Opin Ther Targets; 2011 Feb; 15(2):207-18. PubMed ID: 21204728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting non-canonical nuclear factor-κB signalling attenuates neovascularization in a novel 3D model of rheumatoid arthritis synovial angiogenesis.
    Maracle CX; Kucharzewska P; Helder B; van der Horst C; Correa de Sampaio P; Noort AR; van Zoest K; Griffioen AW; Olsson H; Tas SW
    Rheumatology (Oxford); 2017 Feb; 56(2):294-302. PubMed ID: 27864565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIK inhibitor impairs chronic periodontitis via suppressing non-canonical NF-κB and osteoclastogenesis.
    Wang J; Wang B; Lv X; Wang L
    Pathog Dis; 2020 Oct; 78(7):. PubMed ID: 32860691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional Deletion of NF-κB-Inducing Kinase (NIK) in Adult Mice Disrupts Mature B Cell Survival and Activation.
    Brightbill HD; Jackman JK; Suto E; Kennedy H; Jones C; Chalasani S; Lin Z; Tam L; Roose-Girma M; Balazs M; Austin CD; Lee WP; Wu LC
    J Immunol; 2015 Aug; 195(3):953-64. PubMed ID: 26116508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.
    Matsushima A; Kaisho T; Rennert PD; Nakano H; Kurosawa K; Uchida D; Takeda K; Akira S; Matsumoto M
    J Exp Med; 2001 Mar; 193(5):631-6. PubMed ID: 11238593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-κB-inducing kinase (NIK) is activated in pancreatic β-cells but does not contribute to the development of diabetes.
    Xiao P; Takiishi T; Violato NM; Licata G; Dotta F; Sebastiani G; Marselli L; Singh SP; Sze M; Van Loo G; Dejardin E; Gurzov EN; Cardozo AK
    Cell Death Dis; 2022 May; 13(5):476. PubMed ID: 35589698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling the fate of NIK: a central stage in noncanonical NF-kappaB signaling.
    Sun SC
    Sci Signal; 2010 May; 3(123):pe18. PubMed ID: 20501935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells.
    Sasaki Y; Calado DP; Derudder E; Zhang B; Shimizu Y; Mackay F; Nishikawa S; Rajewsky K; Schmidt-Supprian M
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10883-8. PubMed ID: 18663224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.